Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group

Caminati, Marco; Fassio, Angelo; Alberici, Federico; Baldini, Chiara; Bello, Federica; Cameli, Paolo; Conticini, Edoardo; Cottin, Vincent; Crimi, Claudia; Dagna, Lorenzo; Delvino, Paolo; Deroux, Alban; Duran, Emine; Espigol-Frigole, Georgina; Karadag, Omer; Maule, Matteo; Moiseev, Sergey; Monti, Sara; Moroni, Luca; Padoan, Roberto; Pugnet, Gregory; Taille, Camille; Toniati, Paola; Vaglio, Augusto; Emmi, Giacomo

doi:10.1111/all.15934

Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group

Caminati, Marco;Fassio, Angelo;Alberici, Federico;Baldini, Chiara;Bello, Federica;Cameli, Paolo;Conticini, Edoardo;Cottin, Vincent;Crimi, Claudia;Dagna, Lorenzo;Delvino, Paolo;Deroux, Alban;Duran, Emine;Espigol-Frigole, Georgina;Karadag, Omer;Maule, Matteo;Moiseev, Sergey;Monti, Sara;Moroni, Luca;Padoan, Roberto;Pugnet, Gregory;Taille, Camille;Toniati, Paola;Vaglio, Augusto;Emmi, Giacomo

2023-01-01

Scheda breve

Scheda completa

Scheda completa (DC)

	Anno
	
				2023
			
	Parole chiave
	
				EGPA
T2 inflammation
benralizumab
dupilumab
eosinophilic granulomatosis with polyangiitis
mepolizumab
monoclonal antibodies
omalizumab
reslizumab
severe asthma
			
	Appare nelle tipologie:
	
				1.1 Articolo in rivista

File in questo prodotto:

File	Dimensione	Formato
Allergy - 2023 - Caminati - Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal.pdf accesso aperto Tipologia: Versione Editoriale (PDF) Licenza: Creative commons Dimensione 648.33 kB Formato Adobe PDF Visualizza/Apri	648.33 kB	Adobe PDF	Visualizza/Apri